Lactose and lactose derivatives as bioactive ingredients in human nutrition

被引:149
作者
Schaafsma, Gertjan [1 ]
机构
[1] HAN Univ, Fac Hlth & Social Studies, NL-6925 EJ Nijmegen, Netherlands
关键词
D O I
10.1016/j.idairyj.2007.11.013
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Lactose is a unique disaccharide, which occurs exclusively in the milk of mammals. It has wide applications as a food ingredient and in pharmaceutical preparations. Discouragement of milk consumption, because of the existence of lactase deficiency in the majority of the world population, is unjustified, because even in the complete absence of this enzyme, nutritionally significant volumes of milk, corresponding to about 11 g of lactose per day, are well tolerated, if the milk intake is distributed over the day and combined with meals. Lactose has interesting nutritional properties. These include a relatively low sweetening power, calorific value and glycemic index. It also has dietary fibre-like and prebiotic properties and enhances the absorption of calcium and magnesium. Its cariogenicity is low compared with that of other simple carbohydrates. The lactose derivatives lactulose, lactitol and galacto-oligosaccharides find applications in foods and pharmaceutical preparations as prebiotics to promote gut health. Similarly to non-digested lactose, these compounds enhance the intestinal absorption of calcium and magnesium. Other lactose-derived compounds (e.g., tagatose and lactobionic acid) have potential applications as bioactive ingredient in foods. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
[1]   Calcium and zinc absorption from lactose-containing and lactose-free infant formulas [J].
Abrams, SA ;
Griffin, IJ ;
Davila, PM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (02) :442-446
[2]  
AMMANN P, 1988, J NUTR, V118, P793
[3]  
[Anonymous], ENCY DAIRY SCI
[4]  
[Anonymous], 2006, PUBL HLTH COUNC NETH
[5]   LACTITOL OR LACTULOSE IN THE TREATMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY - RESULTS OF A METAANALYSIS [J].
BLANC, P ;
DAURES, JP ;
ROUILLON, JM ;
PERAY, P ;
PIERRUGUES, R ;
LARREY, D ;
GREMY, F ;
MICHEL, H .
HEPATOLOGY, 1992, 15 (02) :222-228
[6]   Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants [J].
Boehm, G ;
Lidestri, M ;
Casetta, P ;
Jelinek, J ;
Negretti, F ;
Stahl, B ;
Marini, A .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2002, 86 (03) :178-181
[7]   Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans [J].
Bouhnik, Y ;
Flourie, B ;
DAgayAbensour, L ;
Pochart, P ;
Gramet, G ;
Durand, M ;
Rambaud, JC .
JOURNAL OF NUTRITION, 1997, 127 (03) :444-448
[8]  
*BRIT NUTR FDN, 1987, SUG SYR REP BRIT NUT
[9]   Lactulose, disaccharides and colonic flora - Clinical consequences [J].
Clausen, MR ;
Mortensen, PB .
DRUGS, 1997, 53 (06) :930-942
[10]  
Dahlqvist A., 1984, Nutrition Abstracts and Reviews, A (Human and Experimental), V54, P649